AbbVie was also recognized again with Specialty Awards in the categories of Innovation, On-time, Reputation, Right First Time, State-of-the-Art, and Strength of Science.
“Life Science Leader’s CMO Awards are the most meaningful in the drug development and manufacturing outsourcing industry. Each award represents the highest level of accomplishment as evaluated by actual customers. An award in any of the categories assessed, including capabilities, compatibility, expertise, quality, reliability, and service, acknowledges the advanced leadership and execution at the CMO recipient. Congratulations to this year’s CMO Award winners — you keep the industry moving forward.” says Louis Garguilo, Chief Editor and Conference Chair, Outsourced Pharma.
The magazine has issued CMO Awards annually since 2011, and AbbVie has received recognition each year.
“Industry Standard Research continues to consider it an honor to provide the primary market research data for Life Science Leader’s CMO Leadership Awards. ISR’s stringent screening processes ensures that only highly qualified industry decision-makers participate in our contract manufacturing benchmarking market research. This is paramount as we ask the research participants to provide experiential, not perceptual, feedback on their involvement with contract suppliers over the past 18 months. The data enables users of ISR’s market research to make confident business decisions based on the experiences of their industry peers.” Andrew Schafer, President of Industry
For more than 40 years, AbbVie has provided CMO services for biologics, potent drugs, oral solid dose, fermentation, prefilled syringes, hot melt extrusion, fill/finish and APIs.
Daniela Ottini, Vice President, Operations Contract Manufacturing, says “This is a significant award, as it is based on operational performance as rated by our current clients, demonstrating their level of satisfaction at our effectiveness and efficiency. This recognition is shared across AbbVie Operations as a whole, as our contract manufacturing capabilities could not be delivered without close partnership with all functional areas”.
